Ensign Peak Advisors
KZIA

Ensign Peak Advisors’s Kazia Therapeutics KZIA Stock Holding History

Ensign Peak Advisors’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
+110,778
New +$1.35M ﹤0.01% 787

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Ensign Peak Advisors's KZIA Position: Q2 2026 in Review

Ensign Peak Advisors opened a new position in Kazia Therapeutics (KZIA) in Q2 2026: 110,778 shares worth $1.56M. The stake represents ﹤0.01% of the portfolio and ranks #787 among its holdings.

36 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Ensign Peak Advisors held 110,778 shares of Kazia Therapeutics worth $1.56M as of Q2 2026.
  • Kazia Therapeutics was a new Ensign Peak Advisors position in Q2 2026.
  • Kazia Therapeutics made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #787 holding.
  • 36 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.